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by Elsevier B.V. This is an open accesAbstract Despite recent advances in neonatal and perinatal medicine, extremely low birth
weight infants (ELBW) are at high risk of developing anaemia of prematurity (AOP) requiring
packed red blood cell (RBC) transfusions. The benefit of transfusing allogenic RBCs for AOP
is a controversial issue, except for disturbances in tissue oxygenation. Although the role of
erythropoietin (EPO) in the pathophysiology of AOP is well known, neither early nor late re-
combinant human EPO therapy alters the number or volume of RBC transfusions. It is also
known that one-half of the feto-placental blood volume remains outside the newborn infant’s
circulation at 30 weeks of gestation if the umbilical cord is clamped immediately. Delayed cord
clamping (DCC) and umbilical cord milking (UCM) are the main methods for enhancing
placental transfusion. The basic principle of these approaches depends on providing high hae-
moglobin (Hb) levels to premature infants in the delivery room. The enhancement of placental
transfusion clearly results in higher Hb levels at birth, reducing the need for RBC transfusions
as well as creating a better haemodynamic status during the initial hours of life. To date,
enhancement of placental transfusion in the delivery room by either DCC or UCM seems to
be the best preventive measure for AOP. Yet, studies on the associated neurodevelopmental
outcomes are insufficient to reach a conclusion. This review summarizes the pathophysiology,
treatment and preventative strategies of anaemia of prematurity in light of the current liter-
ature.
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Recent advances in perinatal and neonatal medicine and
the broader use of antenatal steroids, exogenous surfac-
tants, sophisticated incubators and ventilator support mo-
dalities have resulted in a remarkable increase in the
survival of preterm infants. Despite these advances,
extremely low birth weight (ELBW) preterm infants remain
at significant risk for the most frequent life-threatening
complications of prematurity, such as intraventricular
haemorrhage (IVH), necrotizing enterocolitis (NEC), reti-
nopathy of prematurity (ROP) and anaemia of prematurity
(AOP) [1]. Preterm infants, particularly those with a birth
weight less than 1500 g, are at high risk of requiring at least
one, and often, multiple red blood cell (RBC) transfusions
[2]. The mean number of transfusions in the two largest
studies ranged from 3.3 to 5.7, depending on whether
restrictive or liberal transfusion guidelines were used [3,4].
Nearly 50% of ELBW infants (or infants born at or before 29
weeks of gestation) receive their first transfusion during the
first 2 weeks of age, and 80% receive at least one additional
blood transfusion by the end of their hospitalization [5].
Although RBC transfusions are a critical part of neonatal
intensive care unit (NICU) stays and can be life saving for
premature infants with severe anaemia or haemorrhage,
they also convey risks and are costly and not easy to utilize,
especially in resource-limited settings [6]. Therefore, pre-
ventive strategies to start life with higher haemoglobin
levels have become popular during the last few decades
[7]. This article reviews preventive strategies for AOP,
giving particular emphasis to the enhancement of placental
transfusion in the delivery room.
2. Anaemia of prematurity
Anaemia of prematurity is a pathological condition unlike
physiologic anaemia in newborns [8]. The pronounced
decline in the haemoglobin (Hb) concentration that occurs
in ELBW infants is usually associated with abnormal clinical
signs and requires allogeneic RBC transfusions [8,9]. AOP is
characterized by reduced endogenous erythropoietin
(EPO), reduced RBC lifespan and hypo-regenerative bone
marrow [7]. Non-physiologic factors related to prematurity,
such as phlebotomy losses for laboratory evaluations and
nosocomial infections resulting in oxidative haemolysis,
also contribute to high transfusion preterm infants [10].
When tissue hypoxia occurs, the transcription and
expression of EPO mRNA increases, followed by an increase
in erythropoiesis. Hypoxia-induced EPO expression is
controlled by an enhancer element called hypoxia inducible
factor-1 (HIF-1). Induction of HIF-1 binding in hypoxic cells
requires RNA and protein synthesis, as well as protein
phosphorylation. Sustained hypoxia is required for
increasing EPO production. EPO production occurs primarily
in the liver before 30 weeks of gestation (and is produced
primarily in the kidney thereafter), and hypoxia is a less
effective isolated stimulus for EPO production and eryth-
ropoiesis. The switch in hypoxia responsiveness and in the
site of EPO production may contribute to AOP [2]. Subop-
timal erythropoiesis appears to be the result of the inade-
quate synthesis of EPO in response to hypoxia [11]. EPOdeficiency is greater in smaller premature infants compared
to less mature infants [12]. Iron, folate, vitamin B12, or
vitamin E deficiencies can also contribute to inadequate
erythropoiesis [11].
Traditionally, AOP has been treated with frequent
packed RBC transfusions [13]. Among all age groups, the
need for allogenic packed RBCs is common in newborns.
Furthermore, preterm infants are among the most heavily
transfused patient populations [3,4]. The goal of packed
RBC transfusions in infants with AOP is to restore or main-
tain oxygen delivery without increasing oxygen consump-
tion [11]. However, according to the UK Serious Hazards of
Transfusion (SHOT) National Haemovigilance Scheme, an
increased number of adverse events related to RBC trans-
fusion occur in children compared to adults, more so in
neonates [14]. There are recognized potential adverse as-
sociations related to RBC transfusions unique to neonates.
For example, associations between RBC transfusions and
NEC, IVH, and chronic lung disease (CLD) as well as mor-
tality have also been described [15e22].
In recent years, most institutes have implemented more
restrictive transfusion guidelines to reduce the number of
transfusions and donor exposures [3,4]. Two larger RCTs
(the Iowa and PINT trials) have examined the transfusion
criteria in the ELBW population. Both trials compared
restrictive with liberal transfusion criteria for clinically
relevant outcomes. Both trials developed transfusion algo-
rithms based on the need for oxygen and the level of res-
piratory support in conjunction with Hb or haematocrit
(Hct) levels [3,4]. Both studies found that neonates in the
restrictive group had fewer RBC transfusions, without an
increase in mortality or morbidity. However, one critical
discrepancy was present. Bell et al [3] described increases
in apnoea, severe IVH and periventricular leukomalacia in
infants transfused with restrictive guidelines, but the trial
was not designed to study these end points. Although the
rates of serious outcomes were fairly high in both groups of
the Kirpalani et al [4] trial, they found no differences in the
rates of serious outcomes between infants in the restrictive
vs. liberal groups.
3. Preventive strategies for anaemia of
prematurity
3.1. Recombinant human EPO
Prevention and treatment of AOP with recombinant human
EPO (r-HuEPO) has been the subject of many randomized
controlled studies for over 20 years among over 3000 infants
[2]. Although the role of EPO in the pathophysiology of AOP
is well known, neither early (2e14 days of life) nor late
(2e3 weeks of life) r-HuEPO therapy, nor co-treatment with
iron, vitamin B12 and folate, alters the number or volume
of RBC transfusions [7]. The combination of early r-HuEPO
and iron does not reduce the RBC transfusion requirements
in infants below 1250 g of birth weight, although the
reticulocyte counts and Hct values are higher in the treat-
ment group [23]. The use of early r-HuEPO does not
significantly reduce the use of one or more RBC transfusions
or the number of RBC transfusions per infant compared with
late r-HuEPO administration. The finding of a statistically
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trend for ROP stage 3 with early EPO treatment is of great
concern [24]. Due to the limited benefits and the possibly
increased risk of ROP, the administration of EPO is not
recommended [25].
The preventive strategies for AOP are summarized in
Fig. 1.
3.2. Reduction of phlebotomy losses
Iatrogenic anaemia due to the repeated removal of blood
for laboratory testing is common in premature infants [11].
During the first postnatal weeks, when severe neonatal
cardiorespiratory illness is at its peak and frequent labo-
ratory testing is most intense, phlebotomy loss among
preterm infants is typically the most important contributor
to AOP and is the reason that a transfusion is required [26].
Strategies for reducing phlebotomy losses include micro-
sampling, batching blood labs, cord blood sampling for
immediate postnatal labs (i.e., blood type and cross-
match), ordering only necessary labs, careful monitoring
of phlebotomy losses, and use of blood-testing devices
operated at the bedside or point of care (POC) devices [27].
Madan et al [28] suggested that after the use of the POC
analyzer in their NICU, the number of RBC transfusions and
the mean volume of RBC transfusions decreased by 43% and
46%, respectively, in infants with birth weights less than
1 kg. Widness et al [29] found that infants who were
examined with an in-line umbilical artery catheter analyser
received a significantly lower amount of RBCs than infants
who were examined according to regular laboratory use
during the first week of life. However, these strategies,
which are dependent on a sophisticated device, are limited
by economic conditions, especially in developing countries.
3.3. Enhancing placental transfusion
In animal studies, it was found that immediate cord
clamping after birth results in the accumulation of
approximately 30%e50% of the feto-placental blood volume
in the placental unit and leaves the newborn with the same
amount of reduced blood volume [30,31]. ApproximatelyFigure 1 Therapeutic and preventive sone-half of the feto-placental blood volume (nearly 110 ml/
kg) remains outside the newborn infant’s circulation at 30
weeks of gestation if the umbilical cord is clamped imme-
diately [31,32]. Aladangady et al [31] were the first group
that demonstrated that the blood volume of ELBW preterm
newborns could be increased by delayed cord clamping
(DCC) for 30e90 s in both vaginal and CS deliveries. The
placental transfusion via DCC was more marked after
vaginal deliveries and seemed to be more apparent for
preterm infants with lower gestational ages [31].
Delayed cord clamping and umbilical cord milking (UCM)
are the main methods for enhancing placental transfusion.
The key difference between DCC and UCM is the mechanism
of cord blood transfer to the infant. In DCC, a passive
transfer of additional blood volume occurs at a slow rate,
mostly by uterine contractions, whereas in UCM, an active
transfer of additional blood volume occurs at a rapid rate
and within a short time [33].
3.4. Delayed cord clamping
A recent Cochrane meta-analysis of data from 15 random-
ized trials with a total of 738 infants who were born be-
tween 24 and 36 weeks’ gestation found that DCC for
30e120 s, rather than immediate clamping, seems to be
associated with less need for transfusion, better circulatory
stability, less IVH and a lower risk for NEC [34]. Concerns
about polycythaemia and hyperbilirubinemia as well as
delays in transition were not included in the review due to
the heterogeneity of the trials [34]. In December 2012, the
American College of Obstetricians and Gynecologists
(ACOG) recommended a 30e60 s delay in umbilical cord
clamping for all preterm deliveries because of the associ-
ated neonatal benefits, including increased blood volume,
reduced need for RBC transfusion, and decreased incidence
of IVH in preterm infants [35]. The “European Consensus
Guidelines on Resuscitation of the Preterm Infant” also
recommended a delay of 30e60 s before clamping the
umbilical cord [36]. In a clinical trial on neuro-
developmental outcomes in preterm infants by Mercer et al
[37], 58 infants who were randomized to DCC (30e45 s) had
similar Bayley II scores with the control group of infants attrategies for anaemia of prematurity.
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DCC on motor scores controlling for gestational age, IVH,
bronchopulmonary dysplasia, sepsis, and male gender sug-
gested higher motor scores in male infants with DCC [38].
More recently, Andersson et al [38] found that DCC
compared with immediate cord clamping improved scores
in the fine-motor and social domains at 4 years of age,
especially in boys who were born at term gestation.
Although DCC has been adopted by many centers in
Canada and Europe, especially in preterm populations, it
has not gained wide acceptance in the United States [39].
Some researchers have noted that DCC may lead to delayed
resuscitation and heat loss in infants who have a lower birth
weight or a shorter gestational age [34,40]. However, it is
already known that neonates who require resuscitation also
need a placental transfusion as much or more so than do
healthy newborns [41]. More recently, Mercer and Erickson-
Owens [41] suggested that an intrapartum care provider
can achieve a placental transfusion for a distressed neonate
by UCM several times or can resuscitate the neonate at the
perineum with an intact cord. Bringing the resuscitation to
the mother’s bedside is a novel concept and supports an
intact cord. Adopting resuscitation with an intact umbilical
cord in a hospital setting will take concentrated effort and
teamwork by midwifery, obstetric, pediatric, and nursing
staff [41]. They also suggested that UCM can be performed
quickly by any intrapartum care provider within the current
Neonatal Resuscitation Program guidelines [41]. Further-
more, a recent Cochrane review concluded that larger
multi-center studies are essential and demand interna-
tional collaboration to provide a scientific rationale for
improving the delivery and resuscitation of the preterm
infant [34]. However, more recently, the 2015 ILCOR sys-
tematic review for the neonatal resuscitation program
suggested that DCC after 30 s is reasonable for both term
and preterm infants who do not require resuscitation at
birth. They did not recommend the routine use of UCM for
ELBW infants due to concerns regarding the safety of rapid
changes in blood volume by UCM for extremely preterm
infants [42].
3.5. Umbilical cord milking
An alternative to DCC is UCM, in which the unclamped
umbilical cord is grasped and blood is pushed toward the
infant several times before it is clamped to auto-infuse
blood into a preterm neonate [43]. Although Beck [44]
proposed this procedure for premature babies in 1941,
the first randomized controlled trial on UCM in premature
babies was published by Hosono et al [40] in 2008. Hosono
et al [40] were able to demonstrate reductions in both the
need for RBC transfusion during the first 3 weeks of life and
the total length of NICU hospitalization with UCM. They
reported that the percentage of infants who had no RBC
transfusions was significantly higher in the UCM group (65%
vs. 30%) [40]. This study showed that UCM is a simple and
cost free method that can reduce the number of RBC
transfusions in preterm infants born at less than 29 weeks’
gestation [40].
A second randomized controlled trial to compare UCM
with ICC was published by March et al [45] in 2013. Theyshowed that preterm infants whose cords were milked had
higher Hb levels at birth and had significantly fewer trans-
fusions in the first 14 days of life. Although the difference in
the incidence of the neonatal transfusions did not reach
statistical significance in their study, a 14.1% decrease was
observed in the UCM group during the first 28 days of life
[45]. Katheria et al [46] designed a randomized controlled
trial including 60 preterm infants to investigate the effect
of UCM on systemic blood flow. They found that preterm
infants randomized to UCM had greater measures of supe-
rior vena cava flow and right ventricular output in the first 6
and 30 h of life. In addition, neonates receiving UCM also
had greater serum Hb levels, received fewer blood trans-
fusions, had fewer days on oxygen therapy, and had less
frequent use of oxygen at 36 weeks’ corrected post-
menstrual age [46]. Our study group [47] previously
demonstrated that UCM resulted in higher Hb levels in very
low birth-weight preterm infants within the first day of life.
However, the number and volume of RBC transfusions was
nearly equal between the UCM and ICC groups by the end of
14 and 35 days of life and during the total length of NICU
stay in our study, probably due to excessive phlebotomy
losses.
More recently, Kilicdag et al [48] found that the absolute
neutrophil counts (ANCs) were lower and the frequency of
neutropenia was higher in the UCM group in their RCT. In
contrast to former RCTs, they did not find any difference
between the UCM and ICC groups in terms of the Hb and Hct
levels [48].
In addition to the trials that compared UCM with ICC,
there are two RCTs that aim to compare UCM with DCC
[43,49]. Rabe et al [49] designed a RCT including 58 pre-
term infants who were randomized either to UCM or DCC for
30 s and found that the number of infants who did not need
a RBC transfusion was not significantly different between
the 2 intervention groups (52% for DCC and 37% for UCM).
Katheria et al [43] found that UCM provides higher initial Hb
levels, higher blood pressure, and improved systemic blood
flow and urine output in preterm infants delivered by
caesarean delivery. However, they did not find any differ-
ence in these parameters in infants delivered by vaginal
delivery and speculated that more blood remained in the
placenta when a neonate was delivered by caesarean sec-
tion because the anaesthetic and surgical interventions
interfered with the active contraction of the uterine mus-
cles to expel the placenta [43]. Katheria et al [43] also
suggested that UCM might be preferable in preterm infants
delivered by caesarean delivery, particularly in newborns
when immediate resuscitation is needed.
In total, umbilical cord milking has been studied in 8
RCTs and 4 controlled trials over the past two decades in
preterm infants (n Z 968) [39,40,43,45e53]. These trials
are summarized in Table 1. The heterogeneity of the
methodologies, primary outcomes and UCM techniques of
these trials is remarkable. Furthermore, the local guide-
lines for RBC transfusions were not specified in most of
these trials, except for the studies by Hosono et al [40],
Rabe et al [49] and Alan et al [47]. Hosono et al [40] and
Rabe et al [49] used more restrictive guidelines for RBC
transfusion than the guideline Alan et al [47] utilized. In
addition, phlebotomy losses were also not specified in
Table 1 A summary of the studies on the effect of umbilical cord milking in preterm infants.
Population Randomization Blindness UCM technique Mode of
delivery
Control
condition
Phlebotomy Guidelines for
RBC transfusion
Primary outcomes
1 Katheria
et al [39],
2015
154 infants,
23e32 wk
Yes Yes 20 cm in 2 s, 4
times
CD DCC with 45 s Not reported Not reported Superior vena cava
flow and right
ventricular output
2 Hosono et al
[48], 2015
40 infants,
<29 wk
No No 20 cm within
2 s, 1 time
CD, NSVD UCM with 20 cm
within 2 s, 2e3
times
The number of
RBC transfusions
and the
probability of not
needing a RBC
transfusion
3 Kilicdag
et al [46],
2015
54 infants,
32 wk
Yes No 20 cm in 2 s, 4
times
CD ICC Not reported Not reported Impact of UCM on
Absolute
neutrophil counts
4 Patel et al
[33], 2014
318 infants,
<30 wk
No No 20 cm within
2 s, 2e3 times
CD, NSVD ICC Not reported Not reported Severe IVH, NEC,
death before
discharge
5 Katheria
et al [40],
2014
60 infants,
23 wk
e31 wk 6 d
Yes Yes 20 cm in 2 s, 3
times
CD, NSVD ICC Not reported Not reported Systemic blood
flow (superior
vena cava flow)
6 Alan et al
[43], 2014
44 infants,
32 wk
Yes No 25e30 cm,
5 cm in 1 s, 3
times
CD, NSVD ICC The median of
38 ml/kg in
UCM and 38 ml/
kg in ICC groups
during the first
35 days of life
Yes the number and
volume of RBC
transfusions
7 Katheria
et al [49],
2014
41 infants,
23 wk
e31 wk 6 d
Yes Yes
(Partial)
20 cm in 2 s, 3
times
CD, NSVD ICC Not reported Not reported HR, SpO2, MAP,
and FiO2 in the
delivery room
8 Christensen
et al [50],
2014
First: 32
infants, 23
e40 wk.
Second: 20
infants,
<32 wk
No No In 10e15 s, 2e4
times
CD, NSVD ICC Not reported Not reported Hyperviscosity in
preterm infants
9 March et al
[42], 2013
75 infants,
24e28
completed
wks
Yes No 20 cm, 3 times CD, NSVD ICC Not reported Not reported The need for RBC
transfusion
10 Takami et al
[51], 2012
50 infants,
<29 wk
No No 20 cm in a s, 2
e3 times
CD, NSVD ICC Not reported Not reported Cerebral and
systemic perfusion
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Hosono et al [40], Rabe et al [49] and Alan et al [47]
(Table 1).
To our knowledge, there are three meta-analyses con-
cerning UCM in preterm infants. A meta-analysis by Al-
Wassia and Shah [33] evaluating the safety and efficacy of
UCM at birth concluded that there was a lower risk for an
oxygen requirement at 36 weeks and IVH of all grades, but
no difference in the risk of mortality. A recent meta-
analysis by Dang et al [54] found that UCM at preterm
birth was comparatively safe and associated with a lower
RBC exposure and lower incidence of IVH, NEC and death.
An additional meta-analysis by Backes et al [55] concluded
that enhanced placental transfusion (DCC or UCM) at birth
provided better neonatal outcomes (reductions in overall
mortality, lower risk of IVH, and decreased RBC transfusion
incidence) in very preterm neonates.
Although the data on neurodevelopmental outcomes in
premature infants are limited, some authors strongly sug-
gest that UCM should no longer be considered experi-
mental; rather, it is a proven intervention that ensures that
premature newborns receive an adequate placental trans-
fusion at birth [44].
4. Conclusion
Due to the increased survival of ELBW infants, AOP has
become a common and serious problem for all NICUs. RBC
transfusion is the only proven treatment strategy for AOP.
However, there are no physiological or laboratory markers
for accurate indicators of requiring RBC transfusion other
than Hb values. Placental/umbilical cord blood was an
untapped resource for premature infants until the last few
decades. After the results and recommendations of the
trials and meta-analyses failed to demonstrate
that neither prevention nor treatment of AOP with r-
HuEPO was effective and safe, the issue of enhanced
placental transfusion has been raised. The methods for
enhancing placental transfusion have many proven bene-
ficial effects in preterm infants. This strategy clearly re-
sults in higher Hb levels at birth and a reduced need for
RBC transfusions, as well as creating a better haemody-
namic status during the initial hours of life. To date, the
enhancement of placental transfusion in the delivery
room either by DCC or UCM seems to be the best pre-
ventive measure for AOP. The effects of placental trans-
fusion probably vary in vaginal deliveries and caesarean
sections. Although the safety of rapid changes in blood
volume via UCM for preterm infants remains a concern,
there are no data for haemodynamic adverse effects up to
now. Furthermore, studies assessing neurodevelopmental
outcomes are insufficient. However, resuscitation events
are not reported consistently, precluding the determina-
tion of the optimal cord clamping practice among neo-
nates born severely depressed or requiring immediate
resuscitation. Large-scale, randomized clinical trials of
enhanced placental transfusion strategies to assess long-
term neurodevelopmental and neurologic sequelae are
needed.
One should also keep in mind that blood elements other
than red blood cells are transfused via DCC or UCM and that
Anaemia of prematurity 105the clinical results of the transfusion of these blood ele-
ments have not been evaluated.
5. Recommendations
 Enhancing placental transfusion by DCC (at least for 30 s)
or UCM (2e4 times) during delivery seems to be the best
approach for preterm infants who do not require resus-
citation. Sufficient data for performing resuscitation
with intact cords are still lacking.
 Cord blood should be used for initial laboratory tests.
 Phlebotomy losses should be reduced.
 Nutrition support with vitamins (folate, B12 and vitamin
E) and iron should be optimized.
 Individual transfusion guidelines should be established
and utilized.Conflict of interest
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